Filing Details
- Accession Number:
- 0001883850-23-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-07 16:09:21
- Reporting Period:
- 2023-02-03
- Accepted Time:
- 2023-02-07 16:09:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-03 | 739 | $764.50 | 32,105 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-02-03 | 3,000 | $381.92 | 35,105 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-03 | 2,248 | $774.29 | 32,857 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-02-06 | 51 | $783.05 | 32,806 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 113 | $784.27 | 32,693 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 78 | $785.88 | 32,615 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 85 | $786.45 | 32,530 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 58 | $787.47 | 32,472 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 99 | $788.62 | 32,373 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 49 | $789.05 | 32,324 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 10 | $790.41 | 32,314 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 3 | $791.00 | 32,311 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 2 | $793.33 | 32,309 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 99 | $794.61 | 32,210 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 59 | $795.41 | 32,151 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 18 | $796.43 | 32,133 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-06 | 28 | $797.43 | 32,105 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-02-03 | 3,000 | $0.00 | 3,000 | $381.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 800 | 2026-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 250 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 113 shares of Company stock on February 6, 2023 at prices ranging from $784.02 to $784.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
- Represents volume-weighted average price of sales of 78 shares of Company stock on February 6, 2023 at prices ranging from $785.85 to $785.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
- Represents volume-weighted average price of sales of 85 shares of Company stock on February 6, 2023 at prices ranging from $786.03 to $786.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
- Represents volume-weighted average price of sales of 99 shares of Company stock on February 6, 2023 at prices ranging from $788.48 to $788.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
- Represents volume-weighted average price of sales of 99 shares of Company stock on February 6, 2023 at prices ranging from $794.28 to $794.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
- Represents volume-weighted average price of sales of 59 shares of Company stock on February 6, 2023 at prices ranging from $795.26 to $795.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
- Represents volume-weighted average price of sales of 18 shares of Company stock on February 6, 2023 at prices ranging from $796.35 to $796.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
